9 результати
BACKGROUND OF THE INVENTION
This invention relates to the treatment of stroke.
Stroke occurs when a section of the brain becomes infarcted, with death of brain tissue following the interruption of cerebral blood supply. The cerebral infarcts associated with acute stroke cause sudden and dramatic
BACKGROUND OF THE INVENTION
Description of the Related Art
The present invention generally relates to the use of sensors to monitor the concentration of a chemical species in bodily fluids. More specifically, the present invention relates to the use of sensors to monitor glucose levels, and/or other
BACKGROUND OF THE INVENTION
1. Field of the Invention
The present invention relates generally to pharmaceutical compositions and medicaments comprising dimethyl sulfoxide (DMSO) and/or related compounds in combination with one or more other compounds, such as L-arginine, fructose 1,6-diphosphate,
TECHNICAL FIELD
The invention is directed to novel inhibitors of biological nitric oxide formation.
BACKGROUND OF THE INVENTION
For several decades nitroglycerin has been administered to humans as a vasodilating agent in the treatment of cardiovascular disease. It has been shown that nitroglycerin
TECHNICAL FIELD
The invention is directed to novel inhibitors of biological nitric oxide formation.
BACKGROUND OF THE INVENTION
For several decades nitroglycerin has been administered to humans as a vasodilating agent in the treatment of cardiovascular disease. It has been shown that nitroglycerin
TECHNICAL FIELD
The invention is directed to novel inhibitors of biological nitric oxide formation.
BACKGROUND OF THE INVENTION
For several decades nitroglycerin has been administered to humans as a vasodilating agent in the treatment of cardiovascular disease. It has been shown that nitroglycerin
TECHNICAL FIELD
The invention is directed to novel inhibitors of biological nitric oxide formation.
BACKGROUND OF THE INVENTION
For several decades nitroglycerin has been administered to humans as a vasodilating agent in the treatment of cardiovascular disease. It has been shown that nitroglycerin
TECHNICAL FIELD
The invention is directed to novel inhibitors of biological nitric oxide formation.
BACKGROUND OF THE INVENTION
For several decades nitroglycerin has been administered to humans as a vasodilating agent in the treatment of cardiovascular disease. It has been shown that nitroglycerin
BACKGROUND OF THE INVENTION
This invention relates to neurology and pharmacology, and to drugs for reducing brain damage in crisis situations such as stroke, cardiac arrest, drowning, or severe blood loss.
Neurons, especially in the central nervous system (CNS), can be severely damaged or killed by